Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules...
Read Story
July 02, 2018, 07:16 AM
|
BIND Therapeutics, Inc., a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court...
Read Story
May 02, 2016, 07:38 AM
|
Hercules Technology Growth Capital, Inc., a leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, announced the company will change its name to Hercules Capital...
Read Story
February 22, 2016, 07:58 AM
|
Hercules Technology Growth Capital, Inc. announced the appointment of Kristen Kosofsky as Senior Managing Director in the Life Sciences Group in Hercules’ Boston office. “I am pleased to welcome Kristen to Hercules and to have such an outstanding and...
Read Story
November 11, 2015, 08:05 AM
|
Hercules Technology Growth Capital announced that Robert Lake has joined the Company as chief credit officer. Lake will report directly to Manuel A. Henriquez, chairman and chief executive officer of Hercules. As chief credit officer, Lake will be...
Read Story
June 02, 2015, 07:58 AM
|
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that it has entered into a loan and security agreement with Hercules...
Read Story
February 25, 2015, 07:10 AM
|
Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting, has entered into a loan and security agreement with Hercules Technology Growth Capital, Inc. for a term loan of up to $26.0 million and completed a private placement for $1.0 million of...
Read Story
January 12, 2015, 07:12 AM
|
Dynavax Technologies Corporation announced that the company has entered into a credit facility with Hercules Technology Growth Capital, Inc. for up to $40 million of total funding. Dynavax drew the first tranche of $10 million on closing and has...
Read Story
December 29, 2014, 07:52 AM
|
nContact, a leader in the development of Arrhythmia Disease Management Programs, announced that it has entered into a $20 million growth capital financing agreement with Hercules Technology Growth Capital, Inc. The company plans to use this financing...
Read Story
November 13, 2014, 07:34 AM
|
Flowonix Medical Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, announced that it has obtained debt and equity financing totaling approximately $40 million.The transaction includes $20 million in...
Read Story
November 12, 2014, 07:26 AM
|
Kevin Grossman joined White Oak Global Advisors, LLC as managing director of originations, responsible for originating and underwriting new investment opportunities for its private debt funds. He brings nearly 20 years of experience in alternative...
Read Story
November 04, 2014, 07:23 AM
|
Gamma Medica, a developer of advanced digital molecular imaging technologies, announced a $6.5 million growth capital financing facility from leading specialty finance company Hercules Technology Growth Capital and $5.0 million from existing investor...
Read Story
October 23, 2014, 07:32 AM
|
Edge Therapeutics has obtained up to $10 million in venture debt financing from Hercules Technology Growth Capital, Inc. to support the continued development of EG-1962, the company’s lead product candidate.“We are very pleased to enter into this...
Read Story
September 09, 2014, 06:49 AM
|
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that its United Kingdom subsidiary, Alimera Sciences Limited (Limited)...
Read Story
April 25, 2014, 07:10 AM
|